Tail Length and E525K Dilated Cardiomyopathy Mutant Alter Human β-Cardiac Myosin Super-Relaxed State
Preprint
Abstract
Dilated cardiomyopathy (DCM) is characterized by impaired cardiac function due to myocardial hypo-contractility and is associated with point mutations in β-cardiac myosin, the molecular motor that powers cardiac contraction. Myocardial function can be modulated through sequestration of myosin motors into an auto-inhibited "super relaxed" state (SRX), which is further stabilized by a structural state known as the "Interacting Heads Motif" (IHM). Therefore, hypo-contractility of DCM myocardium may result from: 1) reduced function of individual myosin, and/or; 2) decreased myosin availability due to increased IHM/SRX stabilization. To define the molecular impact of an established DCM myosin mutation, E525K, we characterized the biochemical and mechanical activity of wild-type (WT) and E525K human β-cardiac myosin constructs that differed in the length of their coiled-coil tail, which dictates their ability to form the IHM/SRX state. Single-headed (S1) and a short-tailed, double-headed (2HEP) myosin constructs exhibited low (∼10%) IHM/SRX content, actin-activated ATPase activity of ∼5s -1 and fast velocities in unloaded motility assays (∼2000nm/s). Double-headed, longer-tailed (15HEP, 25HEP) constructs exhibited higher IHM/SRX content (∼90%), and reduced actomyosin ATPase (-1 ) and velocity (∼800nm/s). A simple analytical model suggests that reduced velocities may be attributed to IHM/SRX-dependent sequestration of myosin heads. Interestingly, the E525K 15HEP and 25HEP mutants showed no apparent impact on velocity or actomyosin ATPase at low ionic strength. However, at higher ionic strength, the E525K mutation stabilized the IHM/SRX state. Therefore, the E525K-associated DCM human cardiac hypo-contractility may be attributable to reduced myosin head availability caused by enhanced IHM/SRX stability. Summary: This research investigates the E525K mutation in human β-cardiac myosin, crucial for heart contraction, and its role in causing Dilated Cardiomyopathy (DCM). It demonstrates that the length of the myosin tail influences its self-inhibition, and the E525K mutation strengthens this effect, potentially reducing heart contractility in DCM.Keywords
All Related Versions
- Published version: Journal of General Physiology, 156 (6).
This publication has 48 references indexed in Scilit:
- Subtle Abnormalities in Contractile Function Are an Early Manifestation of Sarcomere Mutations in Dilated CardiomyopathyCirculation: Cardiovascular Genetics, 2012
- A New State of Cardiac Myosin with Very Slow ATP Turnover: A Potential Cardioprotective Mechanism in the HeartBiophysical Journal, 2011
- Understanding cardiac outputCritical Care, 2008
- Hypertrophic and dilated cardiomyopathy mutations differentially affect the molecular force generation of mouse α-cardiac myosin in the laser trap assayAmerican Journal of Physiology-Heart and Circulatory Physiology, 2007
- Atomic model of a myosin filament in the relaxed stateNature, 2005
- Mutations in the motor domain modulate myosin activity and myofibril organizationJournal of Cell Science, 2003
- Folding of the Striated Muscle Myosin Motor DomainJournal of Biological Chemistry, 2002
- The myosin power strokeCell Motility, 2002
- Myosin step sizeJournal of Molecular Biology, 1990
- Smooth muscle myosin cross-bridge interactions modulate actin filament sliding velocity in vitro.Journal of Cell Biology, 1990